Kazia Therapeutics (KZIA) Total Liabilities (2009 - 2025)
Kazia Therapeutics' (KZIA) quarterly Total Liabilities came in at $16.2 million in Q4 2025, up 13.93% YoY from $14.2 million in Q4 2024, and up 75.94% on a QoQ basis from $9.2 million in Q2 2025.
Kazia Therapeutics (KZIA) Total Liabilities (2009 - 2025) Analysis & Trends
Kazia Therapeutics (KZIA) has 17 years of Total Liabilities data on file, last reported at $16.2 million in Q4 2025.
- Quarterly Total Liabilities rose 13.93% year-over-year to $16.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.2 million (up 13.93% YoY) and the FY2025 annual result came in at $9.2 million, down 55.84% from the prior year.
- Total Liabilities advanced to $16.2 million in Q4 2025, from $9.2 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $20.8 million in Q2 2024 to a low of $9.2 million in Q2 2025.
- A 5-year average of $13.6 million and a median of $13.3 million in 2022 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2021 — Total Liabilities jumped 166.02% — and 2025, when it sank 55.84%.
- Tracing KZIA's Total Liabilities over 5 years: stood at $14.0 million in 2021, then dropped by 23.56% to $10.7 million in 2022, then rose by 16.54% to $12.4 million in 2023, then rose by 14.14% to $14.2 million in 2024, then gained by 13.93% to $16.2 million in 2025.
- The last three Total Liabilities figures came in at $16.2 million (Q4 2025), $9.2 million (Q2 2025), and $14.2 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Kazia Therapeutics | 4.22 Bn | 4.22 Bn | - | 16.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.18 Mn |
| Jun 30, 2025 | 9.20 Mn |
| Dec 31, 2024 | 14.20 Mn |
| Jun 30, 2024 | 20.83 Mn |
| Dec 31, 2023 | 12.44 Mn |
| Jun 30, 2023 | 10.72 Mn |
| Dec 31, 2022 | 10.68 Mn |
| Jun 30, 2022 | 12.62 Mn |
| Dec 31, 2021 | 13.97 Mn |
| Jun 30, 2021 | 15.58 Mn |
| Dec 31, 2020 | 5.80 Mn |
| Jun 30, 2020 | 5.86 Mn |
| Dec 31, 2019 | 5.63 Mn |
| Jun 30, 2019 | 4.89 Mn |
| Dec 31, 2018 | 5.19 Mn |
| Jun 30, 2018 | 6.76 Mn |
| Jun 30, 2017 | 7.94 Mn |
| Dec 31, 2016 | 9.04 Mn |
| Jun 30, 2016 | 7.89 Mn |
| Dec 31, 2015 | 1.28 Mn |